Canadian femtech startup Uresta launches in the U.S.

Uresta, a Canadian femtech startup that develops non-invasive solution for bladder leaks, has officially launched in the U.S. Uresta empowers women to regain confidence and control over stress urinary incontinence (SUI) without surgery or absorbent products. To support its expansion, Uresta recently secured $3 million in funding, including $1.5 million from BDC Capital. This investment will accelerate the company’s U.S. launch and increase awareness of its innovative approach to bladder leakage.

Uresta has been transforming lives by providing a simple, reusable, and comfortable alternative to absorbent products and surgical interventions. Stress urinary incontinence, also known as light bladder leakage, which affects one in three women, this can be described as bladder leakage triggered by physical activity, sneezing, laughing, and coughing. Despite the prevalence of the condition, many women either suffer in silence or resort to ineffective and costly absorbent products. Uresta offers a reusable, hygienic, and comfortable alternative designed to support the bladder to prevent leaks in the first place.

Clinical studies have shown that 97 percent of women saw a reduction of leaks when using Uresta, 90 percent of women continue to use Uresta after 12 months, and 94 percent would recommend Uresta to a friend.

Lauren Barker, CEO and Co-founder, Uresta: "Bringing Uresta to the U.S. is about more than just launching a product – it's about offering women a real solution for bladder leaks. For too long, bladder leaks have controlled the lives of women. Women have been told to tolerate it with absorbent products. Uresta is a simple, non-invasive solution that stops leaks and puts women back in control.”

Uresta has been clinically tested and referenced in a number of global medical journals and is recommended by many pelvic floor physiotherapists and physicians across North America.

www.uresta.com

Follow Marketing Report on LinkedIn